Tags : Molecular Testing

Amgen Collaborates with Guardant Health and Qiagen to Expand Molecular

Shots: Amgen enters into collaboration with Qiagen to develop tissue-based CDx leveraging its Therascreen platform for its investigational AMG 510, identifying patients with KRAS G12C mutation and collaborates with Guardant Health to develop a liquid biopsy CDx identifying patients with actionable alteration in NSCLC Qiagen and Guardant Health will seek regulatory approval including PMA form […]Read More